These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8702752)

  • 41. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
    Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
    Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
    McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
    J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
    Lienenklaus S; Ames RS; Tornetta MA; Sarau HM; Foley JJ; Crass T; Sohns B; Raffetseder U; Grove M; Hölzer A; Klos A; Köhl J; Bautsch W
    J Immunol; 1998 Sep; 161(5):2089-93. PubMed ID: 9725198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
    Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
    J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.
    Buchner RR; Hugli TE; Ember JA; Morgan EL
    J Immunol; 1995 Jul; 155(1):308-15. PubMed ID: 7541417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin.
    Gao J; Choe H; Bota D; Wright PL; Gerard C; Gerard NP
    J Biol Chem; 2003 Sep; 278(39):37902-8. PubMed ID: 12871936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
    Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
    Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin.
    Werfel T; Zwirner J; Oppermann M; Sieber A; Begemann G; Drommer W; Kapp A; Götze O
    J Immunol; 1996 Aug; 157(4):1729-35. PubMed ID: 8759762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First identification of a chemotactic receptor in an invertebrate species: structural and functional characterization of Ciona intestinalis C3a receptor.
    Melillo D; Sfyroera G; De Santis R; Graziano R; Marino R; Lambris JD; Pinto MR
    J Immunol; 2006 Sep; 177(6):4132-40. PubMed ID: 16951378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Derivation of ligands for the complement C3a receptor from the C-terminus of C5a.
    Halai R; Bellows-Peterson ML; Branchett W; Smadbeck J; Kieslich CA; Croker DE; Cooper MA; Morikis D; Woodruff TM; Floudas CA; Monk PN
    Eur J Pharmacol; 2014 Dec; 745():176-81. PubMed ID: 25446428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation.
    Ali H; Tomhave ED; Richardson RM; Haribabu B; Snyderman R
    J Biol Chem; 1996 Feb; 271(6):3200-6. PubMed ID: 8621721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of a functional anaphylatoxin C3a receptor by astrocytes.
    Ischenko A; Sayah S; Patte C; Andreev S; Gasque P; Schouft MT; Vaudry H; Fontaine M
    J Neurochem; 1998 Dec; 71(6):2487-96. PubMed ID: 9832147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
    Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
    Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.
    Busch C; Girke G; Kohl B; Stoll C; Lemke M; Krasnici S; Ertel W; Silawal S; John T; Schulze-Tanzil G
    Mol Immunol; 2013 Apr; 53(4):363-73. PubMed ID: 23070120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.